By Priscilla Villarreal | June 2, 2022

[ays_poll id=3]

Read More

Be Part of the OIS Podcast

By Jackie Wengrod | June 1, 2022

https://ois.net/wp-content/uploads/2022/06/Podcast-Trailer-v2.mp4 [wufoo username=”healthegyrelations” formhash=”q1vc44ob0n17f5b” autoresize=”true” height=”749″ header=”show” ssl=”true”]

Read More
Andrew Stewart - Abbvie

Lessons Learned the Hard Way With AbbVie’s Andrew Stewart

By Jackie Wengrod | April 6, 2022

PODCAST EPISODE 321 Click here to watch the video version of this podcast. When Andrew Stewart moved into his current role of global eye care…

Read More

Intimate Discussions from OIS Israel Innovation Showcase

By Jackie Wengrod | September 1, 2021


Read More

Living the Dream with Donald Korb, OD

By Jackie Wengrod | August 18, 2021


Read More

Israel Ophthalmic Innovation Showcase Briefing

By Jackie Wengrod | June 16, 2021

Market Overview With the largest number of start-ups per capita in the world, Israel is an inimitable center of innovation. In fact, in 2020, Israeli…

Read More
OIS All Stars graphic

OIS All Stars

By Jackie Wengrod | July 2, 2020

[wufoo username=”healthegyrelations” formhash=”q1ez2tws1tiyrs1″ autoresize=”true” height=”866″ header=”show” ssl=”true”]

Read More
OIS Index 5.14.2020

OIS Index Rebounds from March Lows

By Michael Lachman | May 14, 2020

The OIS Index of ophthalmic stocks gained 12.2% in April, participating in the market rebound from the mid-March lows that led to the best month…

Read More
OIS Index Down in February

OIS Index Down in February

By Michael Lachman | March 3, 2020

The OIS Index of ophthalmic stocks declined 9.6% in February, tracking the declines for medical device stocks (-8.7%) and the broader US stock market (-8.4%),…

Read More
OIS Index

OIS Index Gained 2%+ in Jan

By Michael Lachman | February 5, 2020

The OIS Index of ophthalmic stocks gained 2.1% in January, outperforming medical device stocks (+0.1%), the biotech sector (-5.6%%), and the broader US stock market…

Read More
Opthea’s Star Brightens for Stakeholders

Opthea’s Star Brightens for Stakeholders

By Keith Croes | October 30, 2019

It’s been a good year for Opthea Ltd., a biotechnology company based in Melbourne, Australia. It’s listed on the Australian Securities Exchange (ASX), trading as…

Read More
Competition, in Name Only

Competition, in Name Only

By Craig Simak | October 18, 2019

When OIS began 11 years ago, there was nothing like it. We created a unique meeting that catered to industry while others were CME focused.…

Read More


Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.

We respect your privacy and promise to never send you spam.

Something went wrong. Please check your entries and try again.